NRAS and neoplasm: This possibility is further supported by recent data from a large retrospective study of BRAF and NRAS genotyping results demonstrating a small fraction of patients in which both BRAF and NRAS mutations were detected in their tumor specimen, possibly due to intratumor heterogeneity [43].